C-Reactive protein levels but not CRP dynamics predict mortality in patients with pneumococcal pneumonia

Journal of Infection

Volumn 62, Issue 4, 2011, Pages 314-316

  Mooiweer, Erik ^a   Luijk, Bart ^a   Bonten, Marc J M ^a   Ekkelenkamp, Miquel B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREDICTIVE VALUE OF TESTS;

EID: 79953047650     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.01.012     Document Type: Letter

References (11)

1. Moreno M.S., Nietmann H., Matias C.M., Lobo S.M. C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect 2010, 61:205-211. 10.1016/j.jinf.2010.06.005.
2. Clyne B., Olshaker J.S. The C-reactive protein. J Emerg Med 1999, 17:1019-1025.
3. Coelho L., Povoa P., Almeida E., Fernandex A., Mealha R., Moreira R., et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 2007, 11:R92.
4. Bruns A.H., Oosterheert J.J., Hak E., Hoepelman A.I. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008, 32:726-732.
5. Smith R.P., Lipworth B.J., Cree I.A., Spiers E.M., Winter J.H. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995, 108:1288-1291.
6. Hohenthal U., Hurme S., Helenius H., Heiro M., Meurman O., Nikoskelainen J., et al. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia. Clin Microbiol Infect 2009, 15:1026-1032.
7. Krüger S., Ewig S., Kunde J., Hartmann O., Suttorp N., Welte T. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results form the German Competence Network CAPNETZ. Thorax 2010, 65:208-214.
8. Müller B., Süess E., Schuetz P., Müller C., Bingisser R., Bergmann A., et al. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. J Intern Med 2006, 260:568-576.
9. Thiem U., Niklaus D., Sehlhoff B., Stückle C., Heppner H.J., Endres H.G., et al. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing 2009, 38:693-697.
10. Chalmers J.D., Singanayagam A., Hill A.T. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008, 121:219-225.
11. Bartlett J.G., Mundy L.M. Community-acquired pneumonia. N Engl J Med 1995, 333:1618-1624.